RCE News: Recce Pharmaceuticals Granted New Anti-Viral Patent in Australia for RECCE® Anti-Infectives - 4th Aug 2023, 10:00pm

annb0t

Top 20
Recce Pharmaceuticals

SYDNEY, Australia, Aug. 04, 2023 (GLOBE NEWSWIRE) -- Recce Pharmaceuticals Ltd (ASX: RCE, FSE: R9Q), the Company developing a new class of synthetic anti-infectives, is pleased to announce the Australian Patent Office has formally granted Recce a new family four patent, “Process for Preparation of Biologically Active Copolymer,” with expiry in 2041.

“We are thrilled to receive this new family of intellectual property, granted by the Australian Patent Office...

>>> Read more: Recce Pharmaceuticals Granted New Anti-Viral Patent in Australia for RECCE® Anti-Infectives
 
Top Bottom